Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia (REINTEGRA Study)

NCT01309373 is registered in ClinicalTrials.gov with Janssen-Cilag, S.A. as lead sponsor.

NCT NCT01309373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01309373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia (REINTEGRA Study)
Lead sponsor
Janssen-Cilag, S.A.
Phase
Observational
Overall status
Completed
Start date
November 30, 2010
Completion date
August 31, 2011
Enrollment
1,809 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia